Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: -0.50 (-1.59%)
Spread: 2.00 (6.667%)
Open: 31.50
High: 31.50
Low: 31.00
Prev. Close: 31.50
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Certification received to the new MDSAP

20 Mar 2019 07:00

RNS Number : 3569T
Inspiration Healthcare Group PLC
20 March 2019
 

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Certification Received to the new

Medical Device Single Audit Programme

(MDSAP).

 

 Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is pleased to announce that Inspiration Healthcare Ltd, has been certified to the new Medical Device Single Audit Programme (MDSAP). This allows the Company to take advantage of reduced external audits whilst maintaining compliance to four National Standards in the following jurisdictions: Australia, Canada, Japan and the USA. It positions the Company well to increase sales to these territories going forward which in FY2018 represented 5.8% of total sales. At the same time the group achieved certification to EN ISO 13485:2016 for Europe, currently the group's largest international sales region.

The Company is already advancing its plans to transition to the EU Medical Device Regulation by May 2020.

 Commenting, Neil Campbell, CEO said

"We are pleased to have been given this certification today, which involved a time consuming process to align our quality management system to this new auditing framework, and means we can continue to develop sales in these important markets. Obtaining certifications for our products is a very challenging process and in the last year we have significantly improved our capabilities in this area by investing in highly experienced people. The constantly changing regulatory environment necessitates that we continue to invest in this aspect of our business."

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Mike Briant, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

Tel: 07771 713608

 

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support. 

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies. 

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

About MDSAP

The Medical Device Single Audit Program (MDSAP) allows a single audit of a medical device manufacturer's Quality Management System which satisfies the requirements of multiple regulatory jurisdictions.

International partners that are participating in the MDSAP include:

· Australia - Therapeutic Goods Administration of Australia

· Brazil - Agência Nacional de Vigilância Sanitária

· Canada - Health Canada

· Japan - Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices Agency

· USA - The Food and Drug Administration (FDA)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGMGMFNLDGLZM
Date   Source Headline
29th Apr 20217:00 amRNSQueen’s Award for Enterprise for SLE Ltd
29th Apr 20217:00 amRNSTR1 Notification
27th Apr 20217:00 amRNSFinal Results
21st Apr 20217:00 amRNSSLE 6000 & OxyGenie® China approval &250k Order
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
19th Apr 20215:30 pmRNSTR1 Notification
29th Mar 20217:00 amRNSDistribution Agreement and MoU
16th Mar 20217:00 amRNSSLE 6000 & OxyGenie® Japan approval & £400k Order
23rd Feb 20212:10 pmRNSSecond Price Monitoring Extn
23rd Feb 20212:01 pmRNSPrice Monitoring Extension
23rd Feb 202111:06 amRNSSecond Price Monitoring Extn
23rd Feb 202111:01 amRNSPrice Monitoring Extension
18th Feb 20217:00 amRNSResults date and post period end update
15th Feb 20214:41 pmRNSSecond Price Monitoring Extn
15th Feb 20214:36 pmRNSPrice Monitoring Extension
15th Feb 20212:06 pmRNSSecond Price Monitoring Extn
15th Feb 20212:00 pmRNSPrice Monitoring Extension
15th Feb 202111:06 amRNSSecond Price Monitoring Extn
15th Feb 202111:01 amRNSPrice Monitoring Extension
15th Feb 20219:06 amRNSSecond Price Monitoring Extn
15th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20212:06 pmRNSSecond Price Monitoring Extn
11th Feb 20212:01 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSRevenue and Profit Upgrade
21st Jan 20217:00 amRNSExercise of options and Total Voting Rights
14th Jan 20217:00 amRNSTR1 Notification
2nd Dec 20207:00 amRNSEuropean Patent granted for Project WAVE
1st Dec 20201:16 pmRNSInspiration wins AIM Transaction of the Year Award
16th Nov 20207:00 amRNSProject WAVE MHRA Approval
29th Oct 20207:00 amRNSAppointment of Non-Executive Director
6th Oct 20207:00 amRNSInterim Results
23rd Sep 20207:00 amRNSAppointment of Dr. Peter Reynolds
22nd Sep 20207:00 amRNSNotice of Results and Nomination for AIM Awards
16th Sep 20207:00 amRNSVentilator deliveries total £7 million
10th Sep 20203:44 pmRNSTR1 Notification
8th Sep 20207:00 amRNSProject Wave- IRAS submission
26th Aug 202012:12 pmRNSTR1 Notification
20th Aug 20207:00 amRNSUpdate on Ventilator Delivery to the NHS
11th Aug 20207:00 amRNSTrading Update
29th Jul 202011:58 amRNSTR1 Notification
9th Jul 20201:32 pmRNSTR1 Notification
9th Jul 202011:20 amRNSTR1 Notification
9th Jul 202011:17 amRNSTR1 Notification
9th Jul 202011:16 amRNSTR1 Notification
9th Jul 202011:15 amRNSTR1 Notification
9th Jul 202011:15 amRNSTR1 Notification
9th Jul 202011:06 amRNSTR1 Notification
7th Jul 202012:03 pmRNSTR1 Notification
7th Jul 20209:04 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.